AscellaHealth President and CEO Dea Belazi Delivers Impactful Discussion at 2023 SIIA Annual Meeting: Specialty Pharmaceuticals and their Impact on Self-Insured Employers

BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth, a global healthcare and specialty pharmacy SP) solutions company, announces that CEO and President Belazi was invited to participate on a panel during the recent 2023 annual meeting of the Self Insurance Institute of America (SIIA) during a session entitled, “Specialty Pharmaceuticals: Remedy Pain Points for Self-Insured Employers.” Drawing a packed audience, the panel provided expert perspectives for employers, TPAs, brokers and benefits consultants on opportunities to manage quality, access and costs associated with the introduction of specialty medications as well as novel, expensive and potentially lifesaving cell and gene therapies (CGTs).

To read more, click here.